ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $29,000 | -59.7% | 1,100 | -43.6% | 0.00% | -50.0% |
| Q3 2020 | $72,000 | -6.5% | 1,950 | +30.0% | 0.00% | 0.0% |
| Q2 2020 | $77,000 | +63.8% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $47,000 | -62.4% | 1,500 | -28.6% | 0.00% | -50.0% |
| Q4 2019 | $125,000 | +25.0% | 2,100 | -23.6% | 0.00% | +33.3% |
| Q3 2019 | $100,000 | -39.4% | 2,750 | -22.5% | 0.00% | -50.0% |
| Q2 2019 | $165,000 | +2257.1% | 3,550 | +3450.0% | 0.01% | – |
| Q1 2018 | $7,000 | +16.7% | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $99,609,000 | 22.32% |
| Bellevue Group AG | 5,465,715 | $203,160,000 | 2.81% |
| Rhenman & Partners Asset Management AB | 455,000 | $16,912,000 | 1.50% |
| Endurant Capital Management LP | 135,901 | $5,051,000 | 1.49% |
| Boxer Capital, LLC | 975,000 | $36,241,000 | 1.25% |
| DCF Advisers, LLC | 56,500 | $2,100,000 | 1.07% |
| Pentwater Capital Management LP | 2,169,022 | $80,623,000 | 1.04% |
| Nicholas Investment Partners, LP | 235,855 | $8,767,000 | 0.95% |
| Amia Capital LLP | 20,464 | $761,000 | 0.88% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,717,000 | 0.83% |